Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru | Zendy

Jorge A. Gómez | Zendy; María Mercedes Castrejón | Zendy; Nicolas Van de Velde | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru

Author(s) -

Jorge A. Gómez,

María Mercedes Castrejón,

Nicolas Van de Velde

Publication year - 2015

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.6827

Subject(s) - conjugated system , medicine , pneumococcal disease , virology , streptococcus pneumoniae , biology , microbiology and biotechnology , chemistry , polymer , organic chemistry , antibiotics

Dear Editor, We have read with interest the paper by MezonesHolguin et al., 2014 [1] recently published in this journal, reporting the cost effectiveness estimates for pneumococcal conjugated vaccines (PCVs) in Peru. After careful examination of the analysis, we identify some methodological inconsistencies, which we believe would make this study insufficient for decision making. A detailed discussion of these concerns is presented below.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research